37 件 ・ 関連度順
概要と使いどころ
Re-run the analysis pipeline on all runs matching an RQ, reaggregate metrics, and propose findings updates against the fresh data. Trigger when the user says "reanalyze RQ-N", "reanalyse RQ-N", "Runs neu analysieren", or wants to refresh metrics/findings after a pipeline change (analyze-run.sh fix, adapter added, ESLint config).
日本語の概要は準備中です。原文の説明を表示しています。
Generates an experiment-overview snapshot of all research questions under research/reports/. Invoke when a new point-in-time report across all RQs should be produced.
日本語の概要は準備中です。原文の説明を表示しています。
Use this skill to drive a research question (RQ) end-to-end: validate the RQ README, generate a fill batch-plan, start the Docker batch in the background, monitor progress, run aggregation, and propose findings updates. Trigger when the user says "RQ-N voranbringen", "run-rq", "fill RQ-N", "run RQ-N", "Forschungsfrage N starten", or names a specific RQ-N directory in research/.
日本語の概要は準備中です。原文の説明を表示しています。
TDD Test List Phase - Create a comprehensive test list covering every example and rule from the specification
日本語の概要は準備中です。原文の説明を表示しています。
TDD Refactor Phase - Improve code while keeping tests green using Simple Design Rules and APP mass
日本語の概要は準備中です。原文の説明を表示しています。
Mint a new YYYY-MM-DD-exact-coding-baseline snapshot under research/workflow-dev/export/. Detects the current best correctness- oriented workflow from research/workflow-dev/workflow-construction.md (or takes an explicit source-workflow argument) and transforms it from a lab workflow into a consumer-ready one on three axes: strips lab-only measurement content, re-enables human-in-the-loop checkpoints, and converts auto-loading config into an explicitly-invoked skill. Supports both promoted EXACT Coding lines: Opus/Hybrid and SOL/Predictive TDD. Exports Claude Code, pi, OpenCode, cursor-agent and, for SOL, Copilot. Trigger when the user says "exact-coding baseline export", "neue exact-coding baseline", "exact-coding-baseline-export", or asks to refresh the baseline snapshot.
日本語の概要は準備中です。原文の説明を表示しています。
TDD Red Phase - Activate ONE test from the test list and make it fail with explicit predictions
日本語の概要は準備中です。原文の説明を表示しています。
TDD Green Phase - Implement minimal code to make the failing test pass
日本語の概要は準備中です。原文の説明を表示しています。
このリポジトリでワークツリーを作成・利用・片付けるときの手順。git wt でブランチ用のワークツリーを作るとき、ワークツリーでサービス起動・DB操作・テストを行うとき、作業が終わってワークツリーを削除するときに使う。
Implements multiplicity control for confirmatory clinical trials using graphical procedures (Bretz-Maurer-Hommel), gatekeeping (parallel, serial, mixed), Hochberg/Hommel/Holm with PRDS, and the closed-testing principle (Marcus-Peritz-Gabriel; Goeman 2021 admissibility). Covers FDA Multiple Endpoints Final Guidance (October 2022), graphical procedures via R gMCP, primary + key-secondary + subgroup hierarchies, and FWER vs FDR distinction. Use when designing the multiplicity strategy for confirmatory trials with multiple primary or key secondary endpoints.
日本語の概要は準備中です。原文の説明を表示しています。
Runs a route through ScenarioRunner's RouteScenario mode (--route / --route-id) with an autonomous agent driving the ego — the same mechanism the CARLA Leaderboard uses, and the only way to reach the ~34 route-only scenario classes (Accident, ParkedObstacle, HazardAtSideLane, InvadingTurn, HardBreakRoute, YieldToEmergencyVehicle, junction and actor-flow scenarios). Inspects route files, lists route ids and their scenarios, and runs one or all of them. Use when the user asks to "run a route", "drive a route with my agent", "run leaderboard scenarios without the leaderboard", or names a route-only scenario type.
日本語の概要は準備中です。原文の説明を表示しています。
Implements multiplicity control for confirmatory clinical trials using graphical procedures (Bretz-Maurer-Hommel), gatekeeping (parallel, serial, mixed), Hochberg/Hommel/Holm with PRDS, and the closed-testing principle (Marcus-Peritz-Gabriel; Goeman 2021 admissibility). Covers FDA Multiple Endpoints Final Guidance (October 2022), graphical procedures via R gMCP, primary + key-secondary + subgroup hierarchies, and FWER vs FDR distinction. Use when designing the multiplicity strategy for confirmatory trials with multiple primary or key secondary endpoints.
日本語の概要は準備中です。原文の説明を表示しています。
Implements multiplicity control for confirmatory clinical trials using graphical procedures (Bretz-Maurer-Hommel), gatekeeping (parallel, serial, mixed), Hochberg/Hommel/Holm with PRDS, and the closed-testing principle (Marcus-Peritz-Gabriel; Goeman 2021 admissibility). Covers FDA Multiple Endpoints Final Guidance (October 2022), graphical procedures via R gMCP, primary + key-secondary + subgroup hierarchies, and FWER vs FDR distinction. Use when designing the multiplicity strategy for confirmatory trials with multiple primary or key secondary endpoints.
日本語の概要は準備中です。原文の説明を表示しています。